BV Treatment Online in Vermont (Bacterial Vaginosis)

TeleDirectMD operates as a cash-pay practice in Vermont. Your $79 visit fee is paid at booking. Prescription costs are filled separately at your pharmacy and may be covered by your pharmacy benefit. HSA and FSA cards are accepted. There is no insurance billing in Vermont — straightforward, transparent pricing.

Yes. 18 V.S.A. Chapter 219 (Vermont's telemedicine statute) — permits Vermont-licensed physicians to diagnose and treat bacterial vaginosis (BV) by synchronous video visit. The Vermont Board of Medical Practice holds telehealth physicians to the same standard of care as in-person physicians. Classic BV — thin grayish-white discharge with fishy odor, minimal itching, negative for STI symptoms — can be reliably evaluated by detailed symptom history. Per the CDC STI Treatment Guidelines 2021, metronidazole 500 mg twice daily × 7 days or metronidazole vaginal gel 0.75% × 5 days are the recommended first-line treatments. TeleDirectMD self pay is $79.

BV is caused by a disruption of the normal vaginal microbiome — a shift from Lactobacillus-dominant flora to a polymicrobial environment including Gardnerella vaginalis, Prevotella species, Mycoplasma hominis, and other anaerobes. According to the CDC STI Treatment Guidelines 2021, BV is not definitively classified as an STI, though sexual activity is associated with altered vaginal flora. Risk factors include new or multiple sexual partners, douching (which disrupts flora), and lack of Lactobacillus-dominant flora.

Bacterial vaginosis is the most common vaginal infection in women of reproductive age in the United States. The CDC reports that BV affects approximately 21.2 million women aged 14–49 in the US — about 29% of this age group. Vermont's approximately 10 million reproductive-age women thus represent a substantial at-risk population. BV is underdiagnosed because many women are asymptomatic (approximately 50–75% of BV cases) and may not seek care. When symptomatic, BV is associated with discharge, odor, and discomfort that significantly impacts quality of life.

BV and yeast infections (VVC) are distinct conditions requiring different treatments. BV features thin, grayish-white discharge with a characteristic fishy odor that worsens after sex; vaginal pH is elevated (>4.5); itching is usually mild or absent. Yeast infection (VVC) features thick, white, cottage cheese-like discharge without odor; pH is normal (<4.5); and intense itching and burning are hallmarks. Per ACOG Practice Bulletin 215, in-person wet preparation microscopy most reliably differentiates these diagnoses. When symptoms are classical and a prior diagnosis has been established, telehealth evaluation is appropriate.

Per the CDC STI Treatment Guidelines 2021, first-line BV treatments include: metronidazole 500 mg orally twice daily × 7 days (GoodRx ~$12.24 for 14 tablets at goodrx.com); metronidazole vaginal gel 0.75% nightly × 5 days (~$25.07/tube with GoodRx); or clindamycin vaginal cream 2% at bedtime × 7 days (~$30–$50 with coupon). All are equally effective for uncomplicated BV.

BV during pregnancy requires prompt treatment to reduce risk of preterm labor and other complications. However, treatment recommendations differ in pregnancy — oral metronidazole can be used (evidence supports safety in second and third trimesters), but the optimal regimen may differ from non-pregnant treatment. TeleDirectMD does not manage BV in pregnancy. Pregnant patients with BV symptoms should contact their OB/GYN or go to an appropriate in-person provider immediately, as the ACOG recommends screening and treating BV in pregnancy for certain risk groups.

Yes. Recurrent BV is common — approximately 30% of women experience recurrence within 3 months of treatment, per the CDC. Factors contributing to recurrence include disruption of Lactobacillus-dominant flora (douching, antibiotic use, new sexual partners) and partner reinfection. For recurrent BV, extended suppressive therapy with metronidazole vaginal gel twice weekly for 4–6 months may be appropriate — this warrants in-person evaluation and culture. TeleDirectMD can treat acute episodes but recommends in-person evaluation for RVVC workup after multiple recurrences.

Asymptomatic BV in non-pregnant women generally does not require treatment outside of pregnancy or prior to certain gynecologic procedures. The CDC STI Treatment Guidelines 2021 recommend treatment only for symptomatic women — or for asymptomatic BV before procedures such as abortion, hysterectomy, or IUD insertion. In pregnancy, screening and treatment of BV is recommended for women at high risk of preterm birth per ACOG.

Yes. The CDC reports that BV is associated with increased acquisition of HIV, gonorrhea, chlamydia, and other STIs — likely because BV disrupts the normal acidic vaginal environment that protects against pathogens. BV is also associated with increased risk of PID (pelvic inflammatory disease), an upper reproductive tract infection that can cause infertility if untreated. If you have symptoms of both BV and possible STI, in-person testing with STI screening is recommended before starting empiric BV treatment.

Vermont permits electronic prescribing for non-controlled medications and imposes no e-prescribing mandate, per the Vermont Board of Medical Practice. If a prescription is appropriate after your visit, TeleDirectMD sends an e-prescription to your chosen Vermont pharmacy — CVS, Walgreens, Rite Aid, Walmart, Safeway, or other Vermont pharmacy — during or immediately after the visit. Most Vermont pharmacies fill within one to four hours.